Prognostic impact of HbA1c variability on long-term outcomes in patients with heart failure and type 2 diabetes mellitus.

about

Prognostic impact of HbA1c variability on long-term outcomes in patients with heart failure and type 2 diabetes mellitus.

Item

http://www.wikidata.org/entity/Q55516149

description

2018 nî lūn-bûn

@nan

2018年の論文

@ja

2018年学术文章

@wuu

2018年学术文章

@zh-cn

2018年学术文章

@zh-hans

2018年学术文章

@zh-my

2018年学术文章

@zh-sg

2018年學術文章

@yue

2018年學術文章

@zh

2018年學術文章

@zh-hant

name

Prognostic impact of HbA1c var ...... and type 2 diabetes mellitus.

@en

Prognostic impact of HbA1c var ...... and type 2 diabetes mellitus.

@nl

type

Item

label

Prognostic impact of HbA1c var ...... and type 2 diabetes mellitus.

@en

Prognostic impact of HbA1c var ...... and type 2 diabetes mellitus.

@nl

prefLabel

Prognostic impact of HbA1c var ...... and type 2 diabetes mellitus.

@en

Prognostic impact of HbA1c var ...... and type 2 diabetes mellitus.

@nl

P1476

Prognostic impact of HbA1c var ...... e and type 2 diabetes mellitus

@en

P2093

Hui-Li Zhang

http://www.w3.org/2001/XMLSchema#string

Jian-An Pan

http://www.w3.org/2001/XMLSchema#string

Jun Gu

http://www.w3.org/2001/XMLSchema#string

Jun-Feng Zhang

http://www.w3.org/2001/XMLSchema#string

Yu-Qi Fan

http://www.w3.org/2001/XMLSchema#string

P2860

Trends in prevalence and outcome of heart failure with preserved ejection fraction

Outcome of heart failure with preserved ejection fraction in a population-based study

Association of the average rate of change in HbA1c with severe adverse events: a longitudinal evaluation of audit data from the Bavarian Disease Management Program for patients with type 2 diabetes mellitus.

Greater HbA1c variability is associated with increased cardiovascular events in type 2 diabetes patients with preserved renal function, but not in moderate to advanced chronic kidney disease.

Hypo- and hyperglycemia predict outcome in patients with left ventricular dysfunction after acute myocardial infarction: data from EPHESUS.

An unexpected inverse relationship between HbA1c levels and mortality in patients with diabetes and advanced systolic heart failure.

Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes.

2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC). Developed with the special contrib

HbA1C variability and the risk of renal status progression in Diabetes Mellitus: a meta-analysis.

Relation between hemoglobin a(1c) and outcomes in heart failure patients with and without diabetes mellitus.

P2888

s12933-018-0739-3

P304

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/S12933-018-0739-3

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Chang-Qian Wang

P577

2018-06-30T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1105223958

http://www.w3.org/2001/XMLSchema#string

P698

29960591

http://www.w3.org/2001/XMLSchema#string

P921

heart failure

type-2 diabetes

P932

6026342

http://www.w3.org/2001/XMLSchema#string